Back to top stories
PolicyIndia Trending

U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma

The Hindu1h agoAI sentiment: neutral
U.S. FDA issues warning letter to Aurobindo Pharma’s  subsidiary Eugia Pharma

A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator

This summary was generated by PolitGlobe's AI pipeline from publicly available reporting at The Hindu. For the full original article, visit the source below.

Read full article at The Hindu
Advertisement

Related coverage